These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8672826)

  • 41. Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects.
    van Rein N; Gebuis EP; Lijfering WM; Groeneveld JJ; van der Horst FA; le Cessie S; Rosendaal FR; van der Meer FJ
    J Thromb Haemost; 2014 Dec; 12(12):2017-23. PubMed ID: 25308231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Practitioner report involving intravenous use of vitamin K1 prompts label review and revision.
    Burgess TM; Meyer EK; Bataller N
    J Am Vet Med Assoc; 2001 Jun; 218(11):1767-70. PubMed ID: 11394826
    [No Abstract]   [Full Text] [Related]  

  • 43. Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol.
    Berg TM; O'Meara JG; Ou NN; Daniels PR; Moriarty JP; Bergstrahl EJ; Dierkhising RA; Manning DM
    Pharmacotherapy; 2013 Nov; 33(11):1165-74. PubMed ID: 23625787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversal of asymptomatic over-anticoagulation with oral vitamin K.
    Chirputkar SK; Poole HJ; McNeil RC; Tansey P; Etherington AM; Morrison C; Tait RC
    Br J Haematol; 2006 Nov; 135(4):591-2. PubMed ID: 17054668
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coagulation recovery after warfarin-induced hypoprothrombinaemia by oral administration of liposomally-associated vitamin K1 to rabbits.
    Nagata M; Yotsuyanagi T; Nonomura M; Ikeda K
    J Pharm Pharmacol; 1984 Aug; 36(8):527-33. PubMed ID: 6148395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phytonadione therapy in a multiple-drug overdose involving warfarin.
    Bates D; Mintz M
    Pharmacotherapy; 2000 Oct; 20(10):1208-15. PubMed ID: 11034045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of haemorrhagic disease of the newborn. Routine vitamin K1 administration is justified.
    Prescrire Int; 1998 Aug; 7(36):125-7. PubMed ID: 10342952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between fenofibrate and warfarin.
    Ascah KJ; Rock GA; Wells PS
    Ann Pharmacother; 1998; 32(7-8):765-8. PubMed ID: 9681093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practical management of coagulopathy associated with warfarin.
    Garcia D; Crowther MA; Ageno W
    BMJ; 2010 Apr; 340():c1813. PubMed ID: 20404060
    [No Abstract]   [Full Text] [Related]  

  • 52. Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage: is it effective?
    Yamasmit W; Chaithongwongwatthana S; Tolosa JE
    J Reprod Med; 2006 Jun; 51(6):463-6. PubMed ID: 16846083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K.
    Johnson MA
    Nutr Rev; 2005 Mar; 63(3):91-7. PubMed ID: 15825811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cutaneous reactions associated with vitamin K1.
    Wilkins K; DeKoven J; Assaad D
    J Cutan Med Surg; 2000 Jul; 4(3):164-8. PubMed ID: 11003724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of 200μG/day of vitamin K1 on the variability of anticoagulation control in patients on warfarin: a randomized controlled trial.
    Majeed H; Rodger M; Forgie M; Carrier M; Taljaard M; Scarvelis D; Gonsalves C; Rodriguez RA; Wells PS
    Thromb Res; 2013 Sep; 132(3):329-35. PubMed ID: 23953594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phytonadione oral liquid.
    Stumpf JL; Ciarkowski SL; Leja N; Jaynes EK
    Am J Health Syst Pharm; 2016 Jun; 73(12):858-61. PubMed ID: 27261231
    [No Abstract]   [Full Text] [Related]  

  • 57. Warfarin Poisoning with Delayed Rebound Toxicity.
    Berling I; Mostafa A; Grice JE; Roberts MS; Isbister GK
    J Emerg Med; 2017 Feb; 52(2):194-196. PubMed ID: 27838137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative warfarin reversal for early hip fracture surgery.
    Moores TS; Beaven A; Cattell AE; Baker C; Roberts PJ
    J Orthop Surg (Hong Kong); 2015 Apr; 23(1):33-6. PubMed ID: 25920640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.